126 related articles for article (PubMed ID: 36082168)
1. Aptamer-siRNA chimera and gold nanoparticle modified collagen membrane for the treatment of malignant pleural effusion.
Chen W; Guo F; Ren Z; Wang L; Li T; Hou X
Front Bioeng Biotechnol; 2022; 10():973892. PubMed ID: 36082168
[TBL] [Abstract][Full Text] [Related]
2. Construction of Aptamer-siRNA Chimera/PEI/5-FU/Carbon Nanotube/Collagen Membranes for the Treatment of Peritoneal Dissemination of Drug-Resistant Gastric Cancer.
Chen W; Yang S; Wei X; Yang Z; Liu D; Pu X; He S; Zhang Y
Adv Healthc Mater; 2020 Nov; 9(21):e2001153. PubMed ID: 32935949
[TBL] [Abstract][Full Text] [Related]
3. Construction of Durvalumab/carbon nanotube/PEI/aptamer-siRNA chimera for the immunotherapy of hepatocellular carcinoma.
Niu Q; Lv W; Yan T; Wang J; Yan B; Zhou D
Biomed Mater; 2022 Feb; ():. PubMed ID: 35144252
[TBL] [Abstract][Full Text] [Related]
4. Construction of Durvalumab/carbon nanotube/PEI/aptamer-siRNA chimera for the immunotherapy of hepatocellular carcinoma.
Qiang N; Wei L; Tao Y; Jin W; Bin Y; DingHua Z
Biomed Mater; 2022 Feb; 17(2):. PubMed ID: 35147513
[TBL] [Abstract][Full Text] [Related]
5. Construction of an Aptamer-SiRNA Chimera-Modified Tissue-Engineered Blood Vessel for Cell-Type-Specific Capture and Delivery.
Chen W; Zeng W; Sun J; Yang M; Li L; Zhou J; Wu Y; Sun J; Liu G; Tang R; Tan J; Zhu C
ACS Nano; 2015 Jun; 9(6):6069-76. PubMed ID: 26051465
[TBL] [Abstract][Full Text] [Related]
6. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion.
Tseng YH; Ho HL; Lai CR; Luo YH; Tseng YC; Whang-Peng J; Lin YH; Chou TY; Chen YM
J Thorac Oncol; 2018 Mar; 13(3):447-453. PubMed ID: 29246835
[TBL] [Abstract][Full Text] [Related]
8. Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion.
Pan X; Zhong A; Xing Y; Shi M; Qian B; Zhou T; Chen Y; Zhang X
Exp Ther Med; 2016 Oct; 12(4):2161-2168. PubMed ID: 27698705
[TBL] [Abstract][Full Text] [Related]
9. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.
Bagalkot V; Gao X
ACS Nano; 2011 Oct; 5(10):8131-9. PubMed ID: 21936502
[TBL] [Abstract][Full Text] [Related]
10. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Rahme K; Guo J; Holmes JD
Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery.
Nie L; Sun S; Sun M; Zhou Q; Zhang Z; Zheng L; Wang L
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658190
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion.
Chen YQ; Shi HZ; Qin XJ; Mo WN; Liang XD; Huang ZX; Yang HB; Wu C
Am J Respir Crit Care Med; 2005 Dec; 172(11):1434-9. PubMed ID: 16151041
[TBL] [Abstract][Full Text] [Related]
13. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 lineage-specific quantification in malignant pleural effusions of lung adenocarcinoma by flow cytometry.
Yoon JY; Nayyar R; Quest G; Pabedinskas D; Pal P; Tsao MS; Schwock J; Ko HM
Lung Cancer; 2020 Oct; 148():55-61. PubMed ID: 32799091
[TBL] [Abstract][Full Text] [Related]
15. Activation of Valpha24NKT cells in malignant pleural effusion in patients with lung cancer.
Shimizu T; Takahashi N; Terakado M; Tsujino I; Hashimoto S
Oncol Rep; 2009 Sep; 22(3):581-6. PubMed ID: 19639207
[TBL] [Abstract][Full Text] [Related]
16. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
[TBL] [Abstract][Full Text] [Related]
17. A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection.
Han L; Zhao J; Liu J; Duan XL; Li LH; Wei XF; Wei Y; Liang XJ
Biomaterials; 2014 Mar; 35(9):3110-20. PubMed ID: 24411335
[TBL] [Abstract][Full Text] [Related]
18. Delivering siRNA to control osteogenic differentiation and real-time detection of cell differentiation in human mesenchymal stem cells using multifunctional gold nanoparticles.
Wu Q; Wang K; Wang X; Liang G; Li J
J Mater Chem B; 2020 Apr; 8(15):3016-3027. PubMed ID: 32207489
[TBL] [Abstract][Full Text] [Related]
19. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
Front Immunol; 2021; 12():760683. PubMed ID: 34966384
[TBL] [Abstract][Full Text] [Related]
20. [Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1543-6. PubMed ID: 25146741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]